Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the financial results for the period ended September 30, 2025 and 2nd Interim dividend for the Financial Year ending 2025-26